Age, mean years ± SD

46.1 ± 16.8

45.9 ± 19.6

0.98

Sex (Female), number (%)

12 (31.6%)

10 (71.4%)

0.01

Prior TB therapy

0.003

None, number (%)

38 (100%)

11 (78.6%)

Previous TB therapy, number (%)

0

3 (21.4%)

Diagnosis

0.00

Confirmed, number (%)

6 (15.8%)

10 (71.4%)

Probable, number (%)

32 (84.2%)

4 (28.6%)

BMRC severity grade*

0.00

I, number (%)

28 (73.7%)

2 (14.3%)

II, number (%)

6 (15.8%)

3 (21.4%)

III, number (%)

4 (10.5%)

9 (64.3%)

Constitutional symptoms, mean ± SD

2.2 ± 1.1

2.2 ± 0.9

0.87

Headache, number (%)

32 (84.2%)

10 (71.4%)

Nausea/vomiting, number (%)

16 (42.1%)

4 (28.5%)

Fever, number (%)

18 (47.3%)

7 (50.0%)

Loss of consciousness, number (%)

4 (10.5%)

9 (64.2%)

Underlying disease, mean ± SD

0.5 ± 0.8

0.4 ± 0.6

0.48

DM, number (%)

11 (28.9%)

2 (14.2%)

Heart failure, number (%)

2 (5.2%)

1 (7.1%)

Chronic liver disease, number (%)

1 (2.6%)

0

Malignancy, number (%)

1 (2.6%)

1 (7.1%)

Comorbidity, mean ± SD

2.1 ± 0.6

1.4 ± 0.6

0.00

Lung, number (%)

4 (10.5%)

5 (35.7%)

Extrapulmonary lymph node, number (%)

1 (2.6%)

3 (21.4%)

Liver, number (%)

0

1 (7.1%)

TB treatment regimen

0.57

Four-drug

30 (78.9%)

10 (71.4%)

Three-drug

8 (21.1%)

4 (28.6%)

Duration of therapy, median months ± SD

14.8 ± 6.4

14.2 ± 11.5

0.84